Portland, OR, United States of America

Raymond Hickey

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2015-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Raymond Hickey

Introduction

Raymond Hickey is a notable inventor based in Portland, OR (US). He has made significant contributions to the field of biomedical research, particularly in the development of genetically modified pigs for therapeutic purposes. With a total of 2 patents, his work has the potential to impact various medical applications.

Latest Patents

Hickey's latest patents include the creation of Fumarylacetoacetate hydrolase (Fah)-deficient pigs and their uses. This innovation describes the generation of Fah-heterozygote pigs through homologous recombination and somatic cell nuclear transfer. Additionally, it outlines a method for producing Fah-homozygote pigs. The Fah-deficient pigs can be utilized for a variety of research and therapeutic purposes, such as the expansion of human hepatocytes and as large animal models for hereditary tyrosinemia type 1, cirrhosis, and hepatocellular carcinoma.

Career Highlights

Throughout his career, Hickey has worked with esteemed institutions such as Oregon Health & Science University and the Mayo Foundation for Medical Education and Research. His research has focused on advancing the understanding of genetic disorders and developing innovative solutions for treatment.

Collaborations

Hickey has collaborated with notable colleagues in his field, including Markus Grompe and Scott Nyberg. These partnerships have contributed to the success of his research and the advancement of genetic engineering techniques.

Conclusion

Raymond Hickey's contributions to the field of biomedical research through his innovative patents and collaborations highlight his role as a leading inventor. His work continues to pave the way for advancements in medical research and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…